Sponsors (9)
The bill prioritizes parental notice/consent, provider conscience protections, and curbs on federal funding for sex‑trait altering treatments, but does so by significantly restricting access to gender‑affirming care for minors, increasing litigation and administrative burdens, and risking reduced services at federally funded health providers.
Parents and families: federal law would require notice, counseling, and written parental consent before schools or covered providers facilitate sex‑trait altering treatments for minors, preserving parental decision‑making.
Taxpayers and private individuals: the bill creates private causes of action allowing people to sue federal agencies or institutions that use federal funds to support prohibited sex‑trait altering treatments, giving the public an enforcement mechanism beyond executive action.
People who were minors when they received sex‑trait altering treatments: the bill expands civil remedies (longer statute of limitations, ability to recover attorney fees and treble damages) making it easier to sue providers and seek compensation for harms.
Children and transgender patients: the bill would substantially reduce or delay access to gender‑affirming medical care (hormones, puberty blockers, surgeries) for minors and could deter providers from offering such care.
Providers, hospitals, states, and taxpayers: the bill greatly increases litigation exposure (long filing windows, treble damages, private suits against agencies and providers) raising legal costs, insurance premiums, and fiscal risk for institutions and governments.
Underserved communities and local health infrastructure: conditioning or cutting federal funds could cause federally funded hospitals, FQHCs, rural clinics, and medical schools to lose support, reducing local healthcare access, training, and research capacity.
Based on analysis of 11 sections of legislative text.
Conditions federal funding to bar support, promotion, or provision of medical/surgical gender‑transition treatments for minors without parental notification and written consent and creates broad civil remedies.
Introduced March 26, 2025 by Robert F. Onder · Last progress March 26, 2025
Prohibits use of federal funds to pay for, promote, or support medical or surgical gender‑transition treatments for minors unless parents are notified and give written consent; bars federal funding to schools, health care institutions, and states that provide or require such treatments for minors without parental approval. Creates broad private rights of action allowing parents, minors, providers, and even taxpayers to sue federal agencies, states, providers, or institutions for violations; establishes provider notice, consent, and consultation requirements; protects providers who decline to participate in such treatments; and clarifies that gender‑affirming interventions are not ‘‘necessary to the health’’ for a separate criminal‑law provision.